Advanced Tissue Care
The majority of Sonoma Pharmaceuticals advanced tissue care products are based on the Microcyn® Technology platform. To date, Sonoma has obtained 15 clearances from the U.S. Food and Drug Administration, or FDA, along with European Conformity markings (known as Conformeité Européenne or CE) covering 25 products.
Backed by a strong product portfolio, as well as an innovative pipeline of products under development, the Microcyn®-based solutions replace a variety of products currently used for tissue cleaning, debriding and moistening, including sterile saline and chlorhexidine-based products. Sonoma also competes with a large number of prescription and over-the-counter products for the prevention and treatment of infections. Currently, no single anti-infective product dominates the advanced tissue care space due to limiting side effects or the tendency of some products to actually inhibit the healing process. With no contraindications, the Microcyn®-based advanced tissue care products can be used as an adjunctive therapy to further improve patient outcomes.